SOMERSET, N.J., Feb. 5 /PRNewswire-FirstCall/ -- inVentiv Health, Inc. today announced that Eran Broshy, Chairman and Chief Executive Officer and John Emery, Chief Financial Officer will make a presentation at the UBS Global Healthcare Services Conference taking place at The Grand Hyatt in New York February 12-14, 2007. The conference will feature companies spanning all sectors of healthcare, with management presentations and Q&A opportunities.
inVentiv’s presentation will take place on Tuesday, February 13 at 1:00 p.m. in Ballroom D at the Grand Hyatt. An audio webcast of the presentation can be accessed by logging on to http://www.inventivhealth.com/health/newsroom/webCasts.asp .
About inVentiv Health
inVentiv Health is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its three core business segments: inVentiv Clinical, inVentiv Communications and inVentiv Commercial. inVentiv Health currently works with over 200 unique pharmaceutical, biotech and life sciences clients, including all top 20 global pharmaceutical companies. For more information, visit www.inventivhealth.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health’s performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
inVentiv Health, Inc.
CONTACT: Investors/Corporate, John Emery, CFO, +1-732-537-4804,investor@inventivhealth.com, or Media, Felicia Vonella, +1-212-308-7155,fvonella@inventivhealth.com, both for inVentiv Health, Inc.
